NEW YORK (dpa-AFX Broker) - U.S. bank JPMorgan raised its price target for Siemens Healthineers to 70.80 euros from 67.20 euros after the medical technology group's quarterly results and left its rating at 'Overweight'. Due to improving order development reporting, weak diagnostics business and Corindus, the positive aspects of the interim report such as progress in the core business as well as growth in imaging and Varian are not being discussed, analyst David Adlington wrote in a research note issued Thursday. Regarding the new price target, he pointed out that the valuation period for the stock has been pushed further into the future./gl/bek

Publication of the original study: 10.05.2023 / 20:22 / BST

First disclosure of the original study: 11.05.2023 / 00:15 / BST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------